Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HDAC1 | Q13547 | 17/20 | 0.60 |
| ▸ | HDAC6 | Q9UBN7 | 4/20 | 0.60 |
| ▸ | HDAC3 | O15379 | 3/20 | 0.53 |
| ▸ | HDAC4 | P56524 | 3/20 | 0.53 |
| ▸ | HDAC7 | Q8WUI4 | 3/20 | 0.53 |
| ▸ | HDAC2 | Q92769 | 3/20 | 0.53 |
| ▸ | HDAC10 | Q969S8 | 3/20 | 0.53 |
| ▸ | HDAC11 | Q96DB2 | 3/20 | 0.53 |
| ▸ | HDAC8 | Q9BY41 | 3/20 | 0.53 |
| ▸ | HDAC9 | Q9UKV0 | 3/20 | 0.53 |
| ▸ | HDAC5 | Q9UQL6 | 3/20 | 0.53 |
| ▸ | MEN1 | O00255 | 1/20 | 0.51 |
| ▸ | MAPT | P10636 | 1/20 | 0.51 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.51 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL15697598 | 0.87 | MEN1 (0.55) | HDAC1HDAC6MEN1MAPTKMT2A | |
| SCHEMBL16396150 | 0.86 | MEN1 (0.51) | HDAC1HDAC6MEN1MAPTKMT2A | |
| SCHEMBL15698912 | 0.84 | MEN1 (0.70) | HDAC1HDAC6MEN1MAPTKMT2A | |
| SCHEMBL6512630 | 0.84 | HDAC1 (0.63) | HDAC1HDAC6HDAC3HDAC4HDAC7 | |
| SCHEMBL6510207 | 0.83 | HDAC1 (0.55) | HDAC1HDAC6HDAC3HDAC4HDAC7 | |
| SCHEMBL1888015 | 0.82 | MAPT (0.77) | HDAC1HDAC6HDAC3HDAC4HDAC7 | |
| SCHEMBL1889670 | 0.81 | HDAC1 (0.81) | HDAC1HDAC6HDAC3HDAC4HDAC7 | |
| SCHEMBL16396158 | 0.80 | MAPT (0.58) | HDAC1HDAC6MEN1MAPTKMT2A | |
| SCHEMBL16395950 | 0.80 | HDAC1 (0.55) | HDAC1HDAC6HDAC3HDAC4HDAC7 | |
| SCHEMBL6508074 | 0.79 | HDAC1 (0.63) | HDAC1HDAC6HDAC3HDAC4HDAC7 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2005066151-A2 | HISTONE DEACETYLASE INHIBITORS | TAKEDA SAN DIEGO, INC. (US) | 2005-07-21 | — | — | WO | claimed |
| US-20050137234-A1 | Histone deacetylase inhibitors | SYRRX, INC. | 2005-06-23 | — | — | US | claimed |
| WO-2005066151-A2 | HISTONE DEACETYLASE INHIBITORS | TAKEDA SAN DIEGO, INC. (US) | 2005-07-21 | — | — | WO | disclosed |
| WO-2005061486-A1 | CRYSTALLINE FORM OF 2-{4-‘3-(4-CHLORO-2-FLUOROPHENYL)-4-PYRIMIDIN-4-YL-1H-PYRAZOL-5-YL!PIPERIDIN-1-YL}-2-OXOETHANOL | PHARMACIA CORPORATION (US) | 2005-07-07 | — | — | WO | disclosed |
| US-20050137234-A1 | Histone deacetylase inhibitors | SYRRX, INC. | 2005-06-23 | — | — | US | disclosed |
| WO-2005049593-A2 | N-ACYLSULFONAMIDE APOPTOSIS PROMOTERS | ABBOTT LABORATORIES (US) | 2005-06-02 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20050137234-A1 | Histone deacetylase inhibitors | HDAC1, HDAC5, HDAC11 | HDAC1 1/4885HDAC6 10/4885HDAC3 4/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.